PharmAbcine, Inc, a clinical-stage firm developing next generation therapeutics to treat medical needs, declared the decision to accelerate PMC-403, its candidate treatment for neovascular age-related macular degeneration (nAMD), to the fourth...
Synaptogenix, Inc., a growing biopharmaceutical firm developing therapies for neurodegenerative disorders, announced that the Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for Bryostatin-1...
The Government of Kerala has decided to establish an Institute of Organ and Tissue Transplant at Kozhikode. It is being established as an Apex Institute for research, training and patient care in the area of organ transplantation and allied
In India, the annual celebration of National Doctors Day honors and celebrates the significant contributions that physicians make to the lives of individuals and communities. It gives an opportunity to recognize the crucial efforts of doctors...
India's Production Linked Incentive (PLI) program has prompted significant investments in the pharmaceutical industry with the intention of strengthening domestic manufacturing and decreasing import dependence, as per the data from the Department...
Surgence, a cloud-based digital platform developed by Concordance Innovations, a wholly owned subsidiary of Concordance Healthcare Solutions, has announced a collaboration with Mayo Clinic to integrate Surgence into their digital supply chain...
Orchid Pharma Limited, a Chennai-based Indian pharmaceutical firm, has declared the availability of a new drug, cefepime-enmetazobactam, which has been endorsed for the treatment of complex urinary tract infections (cUTI), hospital-acquired...
Bayer, a leading pharmaceutical firm and Rad AI have declared a partnership to offer Rad AI’s advanced AI radiology operational solutions to calantic digital solution customers. In addition to Bayer's CalanticTM Digital Solutions platform, Rad...
Lupin Limited, a leading pharmaceutical firm, declared that it has secured a tentative endorsement from the US Food and Drug Administration (FDA) for its Abbreviated New Medication Application for olopatadine hydrochloride ophthalmic arrangement...
iRegene Therapeutics, an earliest biotech firm in the world focusing on correctly reprograming cell destiny and functions utilizing chemicals, On June 20, the US Food and Drug Administration (FDA) approved the IND application for NouvNeu001...
, CDSCO.jpg)
.jpg)